NHRA - Regulinked.com

NHRA updated “Medicine Submission, Renewal & Variations Guidelines”

NHRA has updated three key pharmaceutical regulatory guidelines in Bahrain as part

NHRA – “Alternative and Complementary Medicines Guideline” (V 1.2)

NHRA issues updated “Alternative and Complementary Medicines Guideline” (V 1.2) 🔍 What’s

Regulinked
November 22, 2025
Guideline
No Comments

NHRA – issues updated “Health Products Licensing Guideline” V 3

NHRA issues updated “Health Products Licensing Guideline” (V 3.0) 🔍 What’s new:

Regulinked
November 22, 2025
Guideline
No Comments

NHRA – issues updated “Medicine Licensing Guideline” V 4.1

NHRA issues updated “Medicine Licensing Guideline” (Version 4.1) 🔍 What’s new:

Regulinked
November 13, 2025
Guideline
No Comments

NHRA – issues updated “Medicine Renewal Guideline” V 2.1 & “Medicine Variations Guideline” V 3.1

NHRA issues updated “Medicine Renewal Guideline” (Version 2.1) & “Medicine Variations Guideline”

Regulinked
November 13, 2025
Guideline
No Comments

NHRA – updated “International Manufacturing Site Licensing Procedure”

NHRA issues updated “International Manufacturing Site Licensing Procedure” Guideline (Version 1.6)

Regulinked
November 10, 2025
Guideline
No Comments

ReguLinked Consulting helps pharmaceutical, healthcare, and life sciences companies achieve seamless market access and regulatory compliance across Saudi Arabia and the GCC. Trusted expertise. Local insight. Real results.

Category: NHRA